Track topics on Twitter Track topics that are important to you
Hepatocellular Carcinoma (HCC) is one of the most common malignant tumors with high incidence and mortality rate. Identification of new, reliable and non invasive biomarkers are important to improve early detection of hepatocellular carcinoma. Circulating micro-RNAs are abundant and play a central role in different biological process of hepatocellular carcinoma. We aimed to evaluate miR-483-5p and miR-133a as potential biomarkers for diagnosis of hepato-cellular carcinoma in cirrhotic patients post chronic hepatitis C virus infection and compare their sensitivity and specificity to currently used alpha fetoprotein test. The study included 20 patients with HCC on top of hepatic cirrhosis post chronic hepatitis C viral infection, 20 patients with hepatic cirrhosis post chronic hepatitis C viral infection, and 20 age and sex matched healthy controls. Serum miRNAs 483 5p and 133a were measured by quantitative real-time polymerase chain reaction (qRT-PCR). Expression levels of miR-483-5p and miR-133a were higher in HCC patients than in patients with liver cirrhosis (P < 0.00).miR-483-5p could predict HCC with sensitivity 100%, specificity 75%, accuracy 0.907, and cut off value > 3.89 while, miR-133a could predict HCC with sensitivity 70%, specificity 90%, accuracy 0.84, and cut off value > 4.79. However, the sensitivity and the specificity of AFP were 80% and 100% respectively. In detecting HCC, combining a-fetoprotein (AFP) and serum miR-483-5p (sensitivity = 95%) and miR 133 a (sensitivity = 90%) were better than AFP alone (sensitivity = 80%). In conclusion; serum miR- 483-5p and miR-133a might serve as noninvasive diagnostic biomarkers for hepatocellular carcinoma. Combination of serum miR-483-5p and miR-133a with AFP might complement the role of AFP in detecting hepatocellular carcinoma.
This article was published in the following journal.
Name: The Egyptian journal of immunology
The identification of high-sensitivity biomarkers for detection of hepatocellular carcinoma (HCC) from high-risk individuals is essential.
Curing hepatitis C virus (HCV) infection reduces the risk of hepatocellular carcinoma (HCC) development, yet HCC occurs despite sustained virologic response (SVR) in 2-8% of cirrhotic patients. Sphing...
The diagnosis of hepatocellular carcinoma (HCC) is usually late, due to the lack of early detection of biomarkers for HCC. Metabolomics analysis has emerged as a useful tool for studying human disease...
The features of non-viral, nonalcohol hepatocellular carcinoma (NBNC-HCC) remain elusive. The aim of this study was to investigate this clinical characteristics and overall survival of NBNC-HCC compar...
Circular RNAs (circRNAs), which are expressed aberrantly in tissues and body fluids in individuals with hepatocellular carcinoma (HCC), may serve as promising biomarkers for diagnosis of HCC. We perfo...
Although the diagnosis and therapy of HCC have being improved, the poor prognosis still remains. To reduce the mortality and improve the effectiveness of diagnosis and therapy, it is impor...
Hepatocellular Carcinoma (HCC) is the fifth most common cancer world-wide. It is particularly prevalent in Asia, and its occurrence is highest in areas where hepatitis B is prevalent, indi...
Hepatocellular carcinoma represents the commonest primary cancer of the liver.serum lactate dehydrogenase is an indirect marker of tumor hypoxia,angioneogenesis and worse prognosis.
The purpose of this study is to evaluate the effect of serum hepatitis B virus (HBV) DNA level on intrahepatic recurrence in locally treatable hepatocellular carcinomas (HCCs) related with...
Hepatocellular carcinoma is one the leading cause of increasing cancer-specific mortality worldwide. Early diagnosis of hepatocellular carcinoma provides opportunity for curative therapeut...
The type species of the genus ORTHOHEPADNAVIRUS which causes human HEPATITIS B and is also apparently a causal agent in human HEPATOCELLULAR CARCINOMA. The Dane particle is an intact hepatitis virion, named after its discoverer. Non-infectious spherical and tubular particles are also seen in the serum.
An ORTHOHEPADNAVIRUS causing chronic liver disease and hepatocellular carcinoma in woodchucks. It closely resembles the human hepatitis B virus.
The first alpha-globulins to appear in mammalian sera during development of the embryo and the dominant serum proteins in early embryonic life. They reappear in the adult serum during certain pathologic states, primarily hepatocellular carcinoma. They may also be elevated in the amniotic fluid and maternal serum during pregnancy in ANENCEPHALY.
A chronic self-perpetuating hepatocellular INFLAMMATION of unknown cause, usually with HYPERGAMMAGLOBULINEMIA and serum AUTOANTIBODIES.
INFLAMMATION of the LIVER with ongoing hepatocellular injury for 6 months or more, characterized by NECROSIS of HEPATOCYTES and inflammatory cell (LEUKOCYTES) infiltration. Chronic hepatitis can be caused by viruses, medications, autoimmune diseases, and other unknown factors.
Astroesophageal Reflux Disease (GERD) Barrett's Esophagus Celiac Disease Cholesterol Crohn's Disease Gastroenterology Hepatitis Hepatology Irritable Bowel Syndrome (IBS) Pancreatitis Peptic Ulcer Disease...
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...